In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

MedImmune Gets Back FluMist: Physicians Will Be Focus Post-Wyeth

Executive Summary

MedImmune is getting "back to basics" on FluMist promotional efforts with a focus on physician education now that the company has regained sole rights to the intranasal flu vaccine from Wyeth
Advertisement

Related Content

ID Biomedical Seeking FluINsure Development Partner For U.S. Market
ID Biomedical Seeking FluINsure Development Partner For U.S. Market
Vaccine Stockpiling Will Not Encourage Development, Wyeth Exec Says
Vaccine Stockpiling Will Not Encourage Development, Wyeth Exec Says
Flu Pandemic Plan Needs To Coordinate Public And Private Vaccine Supplies
Wyeth Prevnar Batches To Ship Soon; Contract Fill/Finish Facility Approved
FluMist Price Likely To Be Cut To $20-$25 Per Dose, MedImmune Says
MedImmune To Continue FluMist Development; Wyeth Remains Undecided
FluMist Arriving Ahead Of Schedule; Could Aid Sales, MedImmune Says
FluMist Arriving Ahead Of Schedule; Could Aid Sales, MedImmune Says
Advertisement
UsernamePublicRestriction

Register

PS043876

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel